Lv5
1190 积分 2022-09-28 加入
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
16天前
已完结
The prostatic acid phosphatase in prostate cancer: A novel theranostic target
17天前
已关闭
A Sequential Population Pharmacokinetic Model of Zilovertamab Vedotin in Patients with Hematologic Malignancies Extrapolated to the Pediatric Population
19天前
已完结
Population Pharmacokinetics of Gemtuzumab Ozogamicin in Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia
22天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
27天前
已完结
Preclinical safety profile of RC88-ADC：a novel mesothelin-targeted antibody conjugated with Monomethyl auristatin E
1个月前
已完结
Preclinical development of MGC028, an ADAM9-targeted, glycan-linked, exatecan-based antibody-drug conjugate for the treatment of solid cancers
1个月前
已完结
Dose optimization and exposure-response analyses to support optimal dose of ABBV-400, a novel C-met–targeting antibody drug conjugate, in patients with metastatic colorectal cancer (mCRC)
2个月前
已完结
Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment
3个月前
已完结
皖公网安备34019202002308
